Back
Collegium Pharmaceutical Vs. RxSight Industry Stock Comparison
Sell
30
COLL
Collegium Pharmaceutical
Last Price:
29.92
Seasonality Move:
19.53%
Sell
6
RXST
RxSight
Last Price:
44.85
Seasonality Move:
35.19%
Sell
30
Collegium Pharmaceutical (COLL)
is a Sell
Is Collegium Pharmaceutical a Buy, Sell or Hold?
- The current Collegium Pharmaceutical [COLL] share price is $29.96. The Score for COLL is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
- COLL is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
6
RxSight (RXST)
is a Sell
Is RxSight a Buy, Sell or Hold?
- The current RxSight [RXST] share price is $44.83. The Score for RXST is 6, which is 88% below its historic median score of 50, and infers higher risk than normal.
- RXST is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
COLL Stock Price Chart
What is Collegium Pharmaceutical's stock price today?
-
The Collegium Pharmaceutical share price today is $29.96
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and COLL is experiencing selling pressure, which indicates risk of future bearish movement.
RXST Stock Price Chart
COLL Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.75 | Sell |
| Relative Strength Index (14 RSI): | 33.15 | Sell |
| Chaikin Money Flow: | -262078 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (30.5 - 35.14) | Sell |
| Bollinger Bands (100): | (32.57 - 38.29) | Sell |
RXST Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.59 | Sell |
| Relative Strength Index (14 RSI): | 37.28 | Sell |
| Chaikin Money Flow: | -218456 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (45.39 - 51.51) | Sell |
| Bollinger Bands (100): | (46.38 - 53.94) | Sell |
COLL Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 29.92 | Buy |
| 20-day SMA: | 32.15 | Sell |
| 50-day SMA: | 35.66 | Sell |
| 200-day SMA: | 35.36 | Sell |
| 8-day EMA: | 30.37 | Sell |
| 20-day EMA: | 31.98 | Sell |
| 50-day EMA: | 34.15 | Sell |
| 200-day EMA: | 33.95 | Sell |
RXST Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 44.79 | Buy |
| 20-day SMA: | 48.1 | Sell |
| 50-day SMA: | 49.48 | Sell |
| 200-day SMA: | 52.75 | Sell |
| 8-day EMA: | 45.39 | Sell |
| 20-day EMA: | 47.07 | Sell |
| 50-day EMA: | 48.99 | Sell |
| 200-day EMA: | 48.78 | Sell |
Collegium Pharmaceutical Earnings Growth & COLL Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.11 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.80 per share, and an increase next year of $0.42 per share.
RxSight Earnings Growth & RXST Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.08 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.96 per share, and an increase next year of $0.29 per share.
Collegium Pharmaceutical Technical Analysis
| Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
RxSight Technical Analysis
| Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||